Fischer Medical Ventures Share Price

Small Cap | Chemicals | BSE: 524743

₹811.00 image-37.65 (-4.44 %)

Last Updated: 02 May 2025 04:01 PM

Technicalsimage BEARISHimage

Overview

Open (₹) 848.00

High (₹) 862.75

Low (₹) 800.00

Prev. Close (₹) 848.65

Volume 2,486

VWAP (₹) 841.41

ROCE (%) 2.64

Industry P/E 41.98

TTM P/E 2079.49

P/B Ratio 53.50

Market Cap (₹) Cr.5,174.31

Dividend Yield (%)--

EPS (₹) 1.08

ROE7.12%

Sales Growth (%) 11588.75

Profit Growth (%)-5,135.34

Day Range

862.75862.75

L
H

52 Week Range

454.35919.00

L
H

Historical Returns

Returns (6M)

27.95 %

Returns (1Y)

61.51 %

Returns (3Y)

1300.69 %

Returns (5Y)

1708.25 %

Returns (6M)

27.95 %

Returns (1Y)

61.51 %

Returns (3Y)

1300.69 %

Returns (5Y)

1708.25 %

SWOT Analysis

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bearish
Bearish

RSI 53.83

MFI 63.77

ATR 56.01

Commodity Channel Index 58.28

ROC125 22.44

ROC21 1.40

Williams %R -58.60

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current875.51932.73965.46842.78785.56752.83695.61
Week Ago829.94854.97874.94809.97784.94764.97739.94
Month Ago811.30829.65839.30801.65783.30773.65755.30

EMA & SMA
info_icon

811.00

Current Price

EMA & SMApin

Bullish Moving Averages

6

Bearish Moving Averages

14

5 Day 813.33


9 Day 819.21


10 Day 822.05


12 Day 828.82


14 Day 826.25

20 Day 823.64


26 Day 819.67


50 Day 782.86


100 Day 734.08


200 Day 686.14

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
ANAND MOHANbulkSell10th Apr, 2023₹79.801,258BSE
KETAN RASHIKLAL DOSHIbulkBuy30th Jun, 2022₹66.60900BSE
KIRTAN JITENDRA BHAI PATELbulkBuy17th Jun, 2022₹79.97996BSE
RAVINDRADADAJIJILTEbulkSell27th Dec, 2021₹93.27973BSE
MOHAMMADZAHIDHUSSAINbulkBuy27th Dec, 2021₹93.201,000BSE
ARUNKUMARbulkBuy23rd Aug, 2021₹90.07932BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
9th Apr, 2025Nikita Sanjay JainAcquisition₹33.204,50,000BSE
9th Apr, 2025Crishi Sanjay JainAcquisition₹33.204,50,000BSE
20th Feb, 2025Time Medical International Ventures Pte LtdAcquisition₹58.5023,00,000BSE
20th Feb, 2025Shankar VaradharajanAcquisition₹58.5017,00,000BSE
27th Jan, 2024Nikita Sanjay JainAcquisition₹8.304,50,000BSE
27th Jan, 2024Crishi Sanjay JainAcquisition₹8.304,50,000BSE
27th Jan, 2024Sanjay Jain HUFAcquisition₹33.202,00,000BSE

Corporate Actions

No corporate actions available.

Announcements

DateSourceDetail
30th Apr, 2025BSE India<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Fischer Medical Ventures Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L86900MH1993PLC288371</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>Nil</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=''float:left;''> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. YES</div> <br/><br/><br/> <div style=''float:left;''> Name of the Company Secretary: ARAVINDKUMAR VENKATASUBRAMANIAN <br/> Designation: COMPANY SECRETARY <br/> EmailId: cs@fischermv.com</div> <div ''style=float:left;margin-left:50px;''> Name of the Chief Financial Officer: VIVEK BALASUBRAMANAN <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: vivek.b@fischermv.com</div> </div> <div> <br/> Date: 30/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
23rd Apr, 2025BSE IndiaIntimation by Material Subsidiary on the Investment
23rd Apr, 2025BSE IndiaFischer Medical Ventures Ltd has informed the exchange on receipt of Central Government Approval for appointment of Managing Director
21st Apr, 2025BSE IndiaUpdate from Material Subsidiary on its proposed investment
21st Apr, 2025BSE IndiaFischer Medical Ventures Limited has informed the exchange on approval for proposed investment as detailed in the annexures to this announcement
10th Apr, 2025BSE IndiaPlease find attached file
9th Apr, 2025BSE IndiaFischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on creation of ISIN with NSDL
9th Apr, 2025BSE IndiaFischer Medical Ventures Limited has allotted 10,50,000 equity shares upon conversion of convertible warrants issued on a preferential basis to non-promoter public category.
9th Apr, 2025BSE IndiaFischer Medical Ventures Limited (formerly known as Fischer Chemic Limited) has informed the exchange on the compliance of Certificate under Regulation 74(5) of SEBI DP Regulations
7th Apr, 2025BSE IndiaIntimation about Investment in Material Subsidiary

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
OthersInter-alia, to consider 1. Appointment of Ms. Jaya Ankur Singhania as Independent Director. 2. Notice of Postal Ballot with explanatory statements and other related matter. 3. Other business matters.25th Mar, 202526th Mar, 2025
Quarterly Results--10th Feb, 202514th Feb, 2025
OthersInter-alia, to consider 1. The withdrawal of the proposed preferential issue. 2. Notice for EGM. 3. To appoint Mr. Nuren Lodaya Practicing Company Secretary. 4. Other business matters.31st Dec, 20243rd Jan, 2025
Quarterly Results--6th Nov, 202413th Nov, 2024
Quarterly Results & Preferential issue--12th Aug, 202414th Aug, 2024
Audited Results--23rd May, 202430th May, 2024
Others--1st May, 20244th May, 2024
Quarterly Results--6th Feb, 202412th Feb, 2024
OthersInter alia, 1. The proposal for fund raising by way of preferential issue / private placement of securities for cash / other than cash, including determination of Issue Price.13th Dec, 202315th Dec, 2023
Quarterly Results--26th Oct, 20231st Nov, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameMar, 2025Dec, 2024Dec, 2023Dec, 2022Dec, 2021
Promoter Group62.81%74.91%0%0%0%
Foreign Institutions +5.23%5.07%0%0%0%
Domestic Institutions +1.44%1.68%0%0%0%
Government0%0%0%0%0%
Public30.52%18.34%100%100%100%
Others0%0%0%0%0%

About Fischer Medical Ventures

Fischer Medical Ventures is a Public Limited Listed company incorporated on 22/03/1993 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231MH1993PLC288371 and registration number is 288371. Currently Company is involved in the business activities of Wholesale of scientific, medical and surgical machinery and equipment. Company’s Total Operating Revenue is Rs. 11.53 Cr. and Equity Capital is Rs. 53.50 Cr. for the Year ended 31/03/2024.

Parent Organisation

Not Applicable

Founded

1993

Managing Director

Mr. Ravindran Govindan

NSE Symbol

--

Fischer Medical Ventures Management

NameDesignation
Mr. Ravindran GovindanChairman & Managing Director
Mr. Jeena Dineshchandra SutharIndependent Director
Mr. Sanjay Jayantilal JainIndependent Director
Mr. Svetlana RaoWhole Time Executive Director
Mr. Khairy Jamaluddin Abu BakkarIndependent Director
Mr. Jacob ThomasIndependent Director
Mr. Roberto M PagdangananIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Deepak Nitrite₹26,400.24₹1,989.60 image
₹1,935.60(2.79%)
₹1,780.500 - ₹3,168.650
Archean Chemical Industries₹7,742.62₹604.65 image
₹627.30(-3.61%)
₹409.000 - ₹831.000
Fischer Medical Ventures₹5,414.52₹811.00 image
₹848.65(-4.44%)
₹454.350 - ₹919.000
Tanfac Industries₹2,877.44₹2,840.00 image
₹2,884.65(-1.55%)
₹1,875.650 - ₹3,970.000
Vishnu Chemicals₹2,861.57₹424.80 image
₹425.10(-0.07%)
₹281.000 - ₹562.000

FAQs on Fischer Medical Ventures

What is the share price of Fischer Medical Ventures?

The share price of Fischer Medical Ventures on 2nd May, 2025 is ₹ 811.00.

What is 52W high and 52W low share price of Fischer Medical Ventures?

The highest and lowest 52W share prices of Fischer Medical Ventures are ₹ 919.000 and ₹ 454.350

What is the market cap of Fischer Medical Ventures?

The market capitalization of Fischer Medical Ventures as of 2nd May, 2025 is ₹ 5,174.31 Crores

What is the P/E ratio of Fischer Medical Ventures?

The current P/E ratio of Fischer Medical Ventures as of 2nd May, 2025 is 41.98

What is the PB ratio of Fischer Medical Ventures?

The PB ratio of Fischer Medical Ventures as of 2nd May, 2025 is 53.50

Top Gainers

₹78.00image

₹65.00 (0.20%)

₹13.15image

₹11.00 (0.20%)

Top Losers

₹107.95image

₹123.00 (-0.12%)

₹0.50image

₹0.56 (-0.11%)

₹24.55image

₹28.11 (-0.13%)

₹3.34image

₹3.80 (-0.12%)

Market Indices

Sensex

₹80,242.24image

₹80,288.38 (0.00%)

Source : Dion Global Solutions Limited